Published • loading... • Updated
GLP-1 Obesity Drugs May Lower Risk of Heart Disease for People With Autoimmune Disease
Summary by EverydayHealth.com
1 Articles
1 Articles
GLP-1 Obesity Drugs May Lower Risk of Heart Disease for People With Autoimmune Disease
Autoimmune diseases raise the risk of heart disease, stroke, and blood clots. For those also living with obesity , these risks climb even higher. New research suggests that GLP-1 drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) may help lower some of those risks. In a study of adults with both obesity and an autoimmune disease, GLP-1 users had lower rates of blood clots, emergency department visits, and death compared with similar peop…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
